Germany
Japan
United Kingdom
China
ST2 mouse monoclonal antibody, clone OTI15A3
Research Areas
Download
ST2 mouse monoclonal antibody, clone OTI15A3
ST2 mouse monoclonal antibody, clone OTI16A7
ST2 mouse monoclonal antibody, clone OTI16A7
ST2 mouse monoclonal antibody, clone OTI17D12
ST2 mouse monoclonal antibody, clone OTI17D12
ST2 mouse monoclonal antibody, clone OTI2C1
ST2 mouse monoclonal antibody, clone OTI2C1
ST2 mouse monoclonal antibody, clone OTI12C9
ST2 mouse monoclonal antibody, clone OTI12C9
ST2 mouse monoclonal antibody, clone OTI2G2
ST2 mouse monoclonal antibody, clone OTI2G2
ST2 mouse monoclonal antibody, clone OTI8G3
ST2 mouse monoclonal antibody, clone OTI8G3
ST2 mouse monoclonal antibody, clone OTI2B4
ST2 mouse monoclonal antibody, clone OTI2B4
ST2 mouse monoclonal antibody, clone OTI3C10
ST2 mouse monoclonal antibody, clone OTI3C10
ST2 mouse monoclonal antibody, clone OTI1F2A8
ST2 mouse monoclonal antibody, clone OTI1F2A8
ST2 mouse monoclonal antibody, clone OTI11A2
ST2 mouse monoclonal antibody, clone OTI11A2
ST2 mouse monoclonal antibody, clone OTI10A2
ST2 mouse monoclonal antibody, clone OTI10A2
ST2 mouse monoclonal antibody, clone OTI11E3
ST2 mouse monoclonal antibody, clone OTI11E3
ST2 mouse monoclonal antibody, clone OTI3A10
ST2 mouse monoclonal antibody, clone OTI3A10
ST2 mouse monoclonal antibody, clone OTI2E9
ST2 mouse monoclonal antibody, clone OTI2E9
ST2 mouse monoclonal antibody, clone OTI21A7
ST2 mouse monoclonal antibody, clone OTI21A7
ST2 mouse monoclonal antibody, clone OTI8H4
ST2 mouse monoclonal antibody, clone OTI8H4
ST2 mouse monoclonal antibody, clone OTI6G4
ST2 mouse monoclonal antibody, clone OTI6G4
ST2 mouse monoclonal antibody, clone OTI1D6
ST2 mouse monoclonal antibody, clone OTI1D6
ST2 mouse monoclonal antibody, clone OTI4F4
ST2 mouse monoclonal antibody, clone OTI4F4
ST2 mouse monoclonal antibody, clone OTI7E9
ST2 mouse monoclonal antibody, clone OTI7E9
ST2 mouse monoclonal antibody, clone OTI9H9
ST2 mouse monoclonal antibody, clone OTI9H9
ST2 mouse monoclonal antibody, clone OTI6C1
ST2 mouse monoclonal antibody, clone OTI6C1
TLR8 mouse monoclonal antibody,clone OTI2F5
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Conjugates
- Unconjugated
Filter by
Target Symbol
- IL6 (128)
- IL1RL1 (105)
- CD4 (86)
- PECAM1 (82)
- PDCD1 (73)
- PTPRC (65)
- CD99 (59)
- LGALS3 (57)
- KIT (55)
- CD68 (54)
- CD5 (51)
- CD19 (50)
- CD274 (48)
- MS4A1 (47)
- NCAM1 (47)
- TNFRSF8 (43)
- ESR1 (42)
- MAPK8 (38)
- CD34 (35)
- MME (34)
- TNF (31)
- IL1RN (30)
- CR2 (29)
- WNT3 (28)
- CD2 (27)
- DVL2 (27)
- FCER2 (26)
- CD22 (25)
- CD33 (25)
- CD14 (24)
- IL2RA (24)
- CRP (23)
- IL3RA (23)
- ANAPC11 (22)
- ROR2 (22)
- RORA (22)
- ANAPC2 (21)
- CD8A (20)
- TYRO3 (20)
- CD79B (19)
- CSF3 (19)
- MAPK9 (19)
- CD3E (17)
- ANPEP (15)
- ITGB3 (15)
- ROCK2 (15)
- FCGR1A (14)
- PTK7 (14)
- CD74 (13)
- LEF1 (13)
- MAPK10 (13)
- ROR1 (13)
- TLR2 (12)
- CASP1 (11)
- CEBPB (11)
- ESR2 (11)
- IL2 (11)
- ITGA2B (11)
- TLR4 (11)
- TLR8 (11)
- WNT1 (11)
- CEBPD (10)
- FZD4 (10)
- IL12B (10)
- IL1B (10)
- IL6R (10)
- WNT5B (10)
- CD79A (9)
- IL6ST (9)
- LRP6 (9)
- POSTN (9)
- ROCK1 (9)
- WNT2B (9)
- ANAPC5 (8)
- CD7 (8)
- IL1A (8)
- IL36G (8)
- ITGAX (8)
- TCF25 (8)
- TLR3 (8)
- WNT3A (8)
- AGTPBP1 (7)
- CD1A (7)
- FZD1 (7)
- FZD8 (7)
- HLA-A (7)
- IL18 (7)
- IL36A (7)
- TCF4 (7)
- TLR5 (7)
- TLR6 (7)
- WNT10A (7)
- WNT16 (7)
- ANAPC10 (6)
- FCGR3A (6)
- FZD10 (6)
- LRP5 (6)
- TCF7L2 (6)
- WNT2 (6)
- WNT5A (6)
Reactivities
- Human (2576)
- Mouse (910)
- Rat (695)
- Monkey (84)
- Dog (70)
- Bovine (27)
- Rabbit (17)
- Chicken (13)
- Hamster (12)
- Canine (11)
- Gorilla (10)
- Bat (9)
- Horse (9)
- Gibbon (8)
- Pig (8)
- Canis (5)
- Chimpanzee (5)
- Porcine (5)
- Primate (5)
- Cow (3)
- Xenopus (3)
- Guinea Pig (2)
- C. elegans (1)
- Equine (1)
- Frog (1)
- Macaque (1)
- Opossum (1)
- Orang-Utan (1)
- Rhesus Monkey (1)
- Sheep (1)
- Squirrel (1)
- Tobacco hornworm (1)
Applications
Antibody Hosts
Isotypes
Clonalities
Carrier-free
Knockout (KO) Validation
Modifications
- Unmodified (86)
- Phospho-specific (30)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho S1490 (1)
- Phospho T183/Y185 (1)
- Phospho T183/Y185,Phospho T221/Y223 (1)
- Phospho T235 (1)
- Phospho Y719 (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Assay Types
Families
- Druggable Genome (1876)
- Transmembrane (1406)
- ES Cell Differentiation/IPS (598)
- Secreted Protein (566)
- Adult stem cells (221)
- Protein Kinase (207)
- Transcription Factors (124)
- Embryonic stem cells (99)
- Stem cell - Pluripotency (87)
- Induced pluripotent stem cells (79)
- Nuclear Hormone Receptor (67)
- Phosphatase (62)
- Protease (61)
- Cancer stem cells (55)
- GPCR (37)
- Stem cell relevant signaling - Wnt Signaling pathway (29)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Hematopoietic cell lineage (721)
- Cell adhesion molecules (CAMs) (525)
- Pathways in cancer (418)
- Cytokine-cytokine receptor interaction (324)
- Toll-like receptor signaling pathway (287)
- T cell receptor signaling pathway (279)
- Wnt signaling pathway (268)
- Melanogenesis (228)
- NOD-like receptor signaling pathway (213)
- Primary immunodeficiency (206)
- Jak-STAT signaling pathway (193)
- Basal cell carcinoma (178)
- Prion diseases (173)
- Graft-versus-host disease (167)
- Leukocyte transendothelial migration (155)
- Colorectal cancer (150)
- Hypertrophic cardiomyopathy (HCM) (148)
- Cytosolic DNA-sensing pathway (136)
- MAPK signaling pathway (127)
- B cell receptor signaling pathway (121)
- Progesterone-mediated oocyte maturation (115)
- Antigen processing and presentation (111)
- Focal adhesion (97)
- Hedgehog signaling pathway (91)
- RIG-I-like receptor signaling pathway (87)
- Fc epsilon RI signaling pathway (81)
- Fc gamma R-mediated phagocytosis (79)
- Adipocytokine signaling pathway (78)
- Type II diabetes mellitus (77)
- Endocytosis (72)
- Neurotrophin signaling pathway (69)
- ErbB signaling pathway (68)
- Regulation of actin cytoskeleton (68)
- Acute myeloid leukemia (67)
- Epithelial cell signaling in Helicobacter pylori infection (66)
- Insulin signaling pathway (64)
- GnRH signaling pathway (63)
- Pancreatic cancer (63)
- Type I diabetes mellitus (55)
- Oocyte meiosis (53)
- Alzheimer's disease (52)
- Apoptosis (52)
- Cell cycle (52)
- Ubiquitin mediated proteolysis (52)
- Pathogenic Escherichia coli infection (51)
- Lysosome (50)
- Allograft rejection (44)
- Renin-angiotensin system (43)
- Systemic lupus erythematosus (39)
- TGF-beta signaling pathway (34)
- Natural killer cell mediated cytotoxicity (32)
- Complement and coagulation cascades (30)
- Dilated cardiomyopathy (30)
- Notch signaling pathway (28)
- Amyotrophic lateral sclerosis (ALS) (27)
- Chemokine signaling pathway (27)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Asthma (26)
- Autoimmune thyroid disease (22)
- Axon guidance (22)
- Vascular smooth muscle contraction (22)
- Endometrial cancer (18)
- Adherens junction (16)
- Prostate cancer (16)
- Viral myocarditis (16)
- Metabolic pathways (15)
- Glutathione metabolism (14)
- Thyroid cancer (14)
- ECM-receptor interaction (13)
- Renal cell carcinoma (7)
- VEGF signaling pathway (7)
- Bladder cancer (6)
- Chronic myeloid leukemia (5)
- Glioma (5)
- Small cell lung cancer (5)
- Long-term depression (4)
- Long-term potentiation (4)
- Melanoma (4)
- Non-small cell lung cancer (4)
- mTOR signaling pathway (4)
- PPAR signaling pathway (3)
- Tight junction (3)
- Gap junction (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- Arginine and proline metabolism (1)
- Huntington's disease (1)
- Inositol phosphate metabolism (1)
- Parkinson's disease (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)